Literature DB >> 20230382

A comparison of the binding of urinary calcium oxalate monohydrate and dihydrate crystals to human kidney cells in urine.

Tingting Wang1, Lauren A Thurgood, Phulwinder K Grover, Rosemary L Ryall.   

Abstract

OBJECTIVE: To compare the binding kinetics of urinary calcium oxalate monohydrate (COM) and dihydrate (COD) crystals to human kidney (HK-2) cells in ultra-filtered (UF), and centrifuged and filtered (CF) human urine; and to quantify the binding of COM and COD crystals to cultured HK-2 cells in UF and CF urine samples collected from different individuals.
MATERIALS AND METHODS: Urine was collected from healthy subjects, pooled, centrifuged and filtered. (14) C-oxalate-labelled COM and COD crystals were precipitated from the urine by adding oxalate after adjustment of two aliquots of the urine to 2 and 8 mm Ca(2+), respectively. For the kinetic study, the crystals were incubated with HK-2 cells for up to 120 min in pooled CF urine adjusted to 2 and 8 mm Ca(2+). Identical experiments were also carried out in UF urine samples collected from the same individuals. For the quantitative study, the same radioactively labelled COM and COD crystals were incubated with HK-2 cells for 50 min in separate CF and UF urines collected from eight healthy individuals at the native Ca(2+) concentrations of the urines. Field emission electron microscopy and Fourier transform-infrared spectroscopy were used to confirm crystal morphology.
RESULTS: COM and COD crystals generally bound more strongly at 8 mm than at 2 mm Ca(2+). The kinetic binding curves of COM were smooth, while those of COD were consistently biphasic, suggesting that the two crystal types induce different cellular metabolic responses: HK-2 cells crystals appear to possess a transitory mechanism for detaching COD, but not COM crystals. In UF urine, COM binding was significantly greater than that of COD at 2 mm Ca(2+), but at 8 mm Ca(2+) the binding of COD was greater at early and late time points. COD also bound significantly more strongly at early time points in CF urine at both 2 and 8 mm Ca(2+). In both CF and UF urine, there was no difference between the binding affinity of urinary COM and COD crystals.
CONCLUSION: Binding of both COM and COD crystals to cultured human renal epithelial cells is influenced by urinary macromolecules and ambient Ca(2+) concentration. HK-2 cells appear to possess a mechanism for the rapid detachment of bound COD crystals, making it difficult to show any unambiguous overall difference between the binding affinity of COM and COD crystals.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230382      PMCID: PMC2902589          DOI: 10.1111/j.1464-410X.2010.09258.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  59 in total

1.  Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals.

Authors:  J C Lieske; F G Toback; S Deganello
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

2.  [Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone].

Authors:  X Parent; G Boess; P Brignon
Journal:  Prog Urol       Date:  1999-12       Impact factor: 0.915

3.  Cytokine production induced by binding and processing of calcium oxalate crystals in cultured macrophages.

Authors:  R de Water; P J Leenen; C Noordermeer; A L Nigg; A B Houtsmuller; D J Kok; F H Schröder
Journal:  Am J Kidney Dis       Date:  2001-08       Impact factor: 8.860

4.  [Correlations between crystalluria and composition of calculi].

Authors:  Z Kaid-Omar; M Daudon; A Attar; A Semmoud; B Lacour; A Addou
Journal:  Prog Urol       Date:  1999-09       Impact factor: 0.915

5.  Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells.

Authors:  Tohru Umekawa; Nasser Chegini; Saeed R Khan
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

6.  Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells.

Authors:  S Thamilselvan; K J Byer; R L Hackett; S R Khan
Journal:  J Urol       Date:  2000-07       Impact factor: 7.450

7.  Osteopontin regulates adhesion of calcium oxalate crystals to renal epithelial cells.

Authors:  Takahiro Yasui; Keiji Fujita; Kiyofumi Asai; Kenjiro Kohri
Journal:  Int J Urol       Date:  2002-02       Impact factor: 3.369

8.  The effects of intracrystalline and surface-bound proteins on the attachment of calcium oxalate monohydrate crystals to renal cells in undiluted human urine.

Authors:  Phulwinder K Grover; Lauren A Thurgood; Tingting Wang; Rosemary L Ryall
Journal:  BJU Int       Date:  2009-08-19       Impact factor: 5.588

9.  High calcium concentration and calcium oxalate crystals cause significant inaccuracies in the measurement of urinary osteopontin by enzyme linked immunosorbent assay.

Authors:  Lauren A Thurgood; Phulwinder K Grover; Rosemary Lyons Ryall
Journal:  Urol Res       Date:  2008-05-14

10.  Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity.

Authors:  M E Roy; S K Nishimoto
Journal:  Bone       Date:  2002-08       Impact factor: 4.398

View more
  10 in total

1.  The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.

Authors:  Lauren A Thurgood; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2011-09-20

Review 2.  Histological aspects of the "fixed-particle" model of stone formation: animal studies.

Authors:  Saeed R Khan
Journal:  Urolithiasis       Date:  2016-11-28       Impact factor: 3.436

3.  Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine.

Authors:  Bernd Grohe; Brian P H Chan; Esben S Sørensen; Gilles Lajoie; Harvey A Goldberg; Graeme K Hunter
Journal:  Urol Res       Date:  2011-01-14

4.  Molecular mechanisms involved in the protective effect of the chloroform extract of Selaginella lepidophylla (Hook. et Grev.) Spring in a lithiasic rat model.

Authors:  Estévez-Carmona María Mirian; Narvaéz-Morales Juanita; Barbier Olivier Christophe; Meléndez-Camargo María Estela
Journal:  Urolithiasis       Date:  2013-03-30       Impact factor: 3.436

5.  Interaction between submicron COD crystals and renal epithelial cells.

Authors:  Hua Peng; Jian-Ming Ouyang; Xiu-Qiong Yao; Ru-E Yang
Journal:  Int J Nanomedicine       Date:  2012-08-29

6.  Reinjury risk of nano-calcium oxalate monohydrate and calcium oxalate dihydrate crystals on injured renal epithelial cells: aggravation of crystal adhesion and aggregation.

Authors:  Qiong-Zhi Gan; Xin-Yuan Sun; Poonam Bhadja; Xiu-Qiong Yao; Jian-Ming Ouyang
Journal:  Int J Nanomedicine       Date:  2016-06-14

7.  Alpha-enolase on apical surface of renal tubular epithelial cells serves as a calcium oxalate crystal receptor.

Authors:  Kedsarin Fong-Ngern; Visith Thongboonkerd
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

8.  Size-dependent cellular uptake mechanism and cytotoxicity toward calcium oxalate on Vero cells.

Authors:  Xin-Yuan Sun; Qiong-Zhi Gan; Jian-Ming Ouyang
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

9.  Response surface methodology based extraction of Tribulus terrestris leads to an upsurge of antilithiatic potential by inhibition of calcium oxalate crystallization processes.

Authors:  Jyoti Kaushik; Simran Tandon; Varun Gupta; Jasamrit Nayyar; Surinder Kumar Singla; Chanderdeep Tandon
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

10.  Roles of Macrophage Exosomes in Immune Response to Calcium Oxalate Monohydrate Crystals.

Authors:  Nilubon Singhto; Rattiyaporn Kanlaya; Angkhana Nilnumkhum; Visith Thongboonkerd
Journal:  Front Immunol       Date:  2018-02-27       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.